GY971 mitigates inflammation by reducing neutrophil recruitment in cystic fibrosis Ex Vivo and In Vivo models
GY971 appears to be a promising molecule for the future development of combinatorial anti-inflammatory treatments together with ETI.
Authors
- Ilaria Lampronti (ORCID: https://orcid.org/0000-0002-1972-7766)
- Onofrio Laselva (ORCID: https://orcid.org/0000-0002-0237-4079)
- Chiara Tupini (ORCID: https://orcid.org/0000-0003-2340-0552)
- Adriana Chilin (ORCID: https://orcid.org/0000-0002-2038-1299)
- Anna Tamanini (ORCID: https://orcid.org/0000-0002-7427-0981)
- Marco Cafora (ORCID: https://orcid.org/0000-0002-5427-8046)
- Giovanni Marzaro (ORCID: https://orcid.org/0000-0002-5892-5992)
- Nicoletta Pedemonte (ORCID: https://orcid.org/0000-0002-5161-1720)
- Anna Pistocchi (ORCID: https://orcid.org/0000-0001-9467-2542)
- Stefania Tacconelli (ORCID: https://orcid.org/0000-0003-4907-1822)
- Paola Patrignani (ORCID: https://orcid.org/0000-0003-1419-2691)
- Valeria Capurro (ORCID: https://orcid.org/0000-0002-9740-1171)
- Caterina Allegretta (ORCID: https://orcid.org/0000-0002-9598-3470)
- Alessandra De Michele
- Giulio Cabrini
Institutions
- University of Foggia (IT)
- University of Verona (IT)
- University of Milan (IT)
- University of Ferrara (IT)
- Istituto Giannina Gaslini (IT)
- University of Chieti-Pescara (IT)
Publication Details
- Journal
- Journal of Cystic Fibrosis
- Published
- 2025-12-23
- DOI
- https://doi.org/10.1016/j.jcf.2025.12.010
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Università degli Studi di Padova
- Università degli Studi di Ferrara
- Fondazione per la Ricerca sulla Fibrosi Cistica